UGCG, or UDP-glucose ceramide glucosyltransferase, serves a pivotal role in the domain of sphingolipid metabolism. This enzyme facilitates the glycosylation step during the synthesis of glycosphingolipids, converting ceramide into glucosylceramide by transferring a glucose residue. Given the central importance of sphingolipids in various cellular processes ranging from cell signaling to apoptosis, the proper regulation and activity of UGCG are paramount. This brings forth a niche of compounds known as UGCG activators. These are molecules specifically designed or discovered to upregulate or enhance the enzymatic activity of UGCG.
UGCG activators, through their action, can have a profound effect on the sphingolipid balance within cells. By promoting the conversion of ceramide to glucosylceramide, these activators can potentially influence the levels of various downstream sphingolipids. The metabolic adjustments that arise due to the action of these activators might have implications for cellular signaling, lipid raft formation, and other processes linked to sphingolipids. Moreover, considering the intricate balance of lipids within cells, UGCG activators might indirectly affect other lipid classes and their associated metabolic pathways. These compounds, when understood deeply, can offer a detailed insight into the broad landscape of lipid metabolism and the sophisticated interplay of enzymes and substrates in maintaining cellular homeostasis.
Items 11 to 12 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Tamoxifen | 10540-29-1 | sc-208414 | 2.5 g | $256.00 | 18 | |
Tamoxifen can affect lipid metabolism and signaling, potentially leading to modulations in UGCG expression. | ||||||
Tunicamycin | 11089-65-9 | sc-3506A sc-3506 | 5 mg 10 mg | $169.00 $299.00 | 66 | |
By impacting glycoprotein synthesis, tunicamycin may induce a cellular response leading to changes in UGCG expression. | ||||||